Happy Thanksgiving!
Happy Thanksgiving from the Boston Harbor Angels!
25
Nov
20
Nov
What Happens When Student Loan Payment Deferral Ends?
The Coronavirus Aid, Relief and Economic Security (CARES) Act included two provisions that were critical to helping Americans with student loan debt. One allowed borrowers to suspend payments through September 30, and that relief was later extended to December 31. Laurel Taylor, founder and CEO of FutureFuel.io, a company that supports student loan borrowers, explains that the payment suspension in the CARES Act allowed anyone who had a federal student loan to get a reprieve. Borrowers could pause their […]
19
Nov
Cognoptix Announces New Scientific Advisory Board with Alzheimer’s Research Leaders
Cognoptix, a leading diagnostics company dedicated to early detection of Alzheimer’s disease (AD), announced today the formation of its new Scientific Advisory Board (SAB) with appointment of five world-class scientists and clinical researchers in AD. The SAB includes Jeffrey L. Cummings, MD, ScD; Lee E. Goldstein, MD, PhD; Philip Scheltens, MD, PhD; Martin R. Farlow, MD; and Carl H. Sadowsky, MD. Drs. Cummings and Goldstein will serve as SAB Clinical and Science Chairs, respectively. Read more >>
19
Nov
YSIF December 10th: How to Raise Angel Capital
Panel featuring Ziad Moukheiber, President and CEO of Boston Harbor Angels.
TOPIC: How to Raise Angel Capital
HOST: Dr. James Boyle, Exec. Director of Venture Development, OCR
MODERATOR: Kristin King, MBA, VP of Corporate Development & Strategy: Defibtech
PRESENTERS/AGENDA:
• Ziad H. Moukheiber: President and CEO, Boston Harbor Angels Inc.
• Anthony Gellert: Founder, Livingston Ventures
Learn more >>
18
Nov
Utah State Board of Education Announces Statewide Access to Scrible to Support Schools with Research and Writing Amid Distance Learning
The Utah State Board of Education (USBE) announces a statewide partnership with Scrible, a modern research and writing platform that supports distance learning. The partnership ensures that every Utah school district has access to Scrible Edu Pro, bringing the company’s full suite of online research and writing tools to more than 665,000 students, teachers and librarians in grades K-12 for the current 2020-21 school year. Read more >>
18
Nov
Aircuity Introduces “Air Quality as a Service” Solution to Accelerate Safer Building Re-openings
Aircuity, the leading provider of measurably better environments, today introduced “Air Quality as a Service” (AQaaS), a new indoor air quality (IAQ) solution that helps building owners create “healthy buildings” that meet both COVID-19 re-entry and longer term air quality requirements. As an operating expenditure, Aircuity’s AQaaS requires no or low upfront capital, making it easier – and faster – to deploy in existing buildings. Read more >>
18
Nov
SAM by ZetrOZ is the New, Go-To, Cost-Effective Treatment for Knee Arthritis Pain
ZetrOZ Systems, developers of Sustained Acoustic Medicine (SAM), a wearable, home-use, FDA-cleared bio regenerative medical device, announces that its product has been recognized as a cost-effective treatment for patients suffering from knee pain relating to arthritis in a recent research study published in the Journal of Orthopaedic Surgery and Research. Read more >>
17
Nov
Esight launches wearable smart assistive device for the visually impaired in Europe
Esight Corp. is starting distribution of its newest low-vision assistive technology in France, Germany and the U.K. The latest version of the technology, the Esight 4, was designed to be more versatile and mobile than before, has double the display brightness and has improved the auto-focus function, according to the company. Read more >>
17
Nov
FDA Clears Neuraly to Begin Phase 2 Trial of NLY01 in Alzheimer’s Patients
The U.S. Food and Drug Administration has given clearance for a Phase 2B clinical trial to evaluate the safety, tolerability, and efficacy of Neuraly’s investigational therapy NLY01 in people with Alzheimer’s disease. The randomized, double-blinded, placebo-controlled trial is expected to enroll more than 500 people with mild cognitive impairment due to Alzheimer’s disease at more than 100 sites in the U.S., Canada, and Europe. Read more >>
17
Nov
Myomo Introduces MyoGames – Video Games Played via MyoPro for Training, Rehabilitation and Fun
Myomo, Inc., a wearable medical robotics company offering increased functionality for individuals suffering from neurological disorders and upper-limb paralysis, announced today the availability of MyoGames by Lusio, a video game platform designed to augment training and rehabilitation for MyoPro users, while being fun. Read more >>